Ara
Toplam kayıt 14, listelenen: 11-14
Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
(Soc Brasileira Dermatologia, 2017)
Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal ...
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PRESENTING WITH THROMBOCYTOPENIA: TWO PESG CASES
(Pergamon-Elsevier Science Ltd, 2017)
Leukocytoclastic vasculitis due to thalidomide
(Elsevier Taiwan, 2017)